Todd Hobbs

1.3k total citations
27 papers, 783 citations indexed

About

Todd Hobbs is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Todd Hobbs has authored 27 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Todd Hobbs's work include Diabetes Treatment and Management (22 papers), Diabetes Management and Research (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Todd Hobbs is often cited by papers focused on Diabetes Treatment and Management (22 papers), Diabetes Management and Research (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Todd Hobbs collaborates with scholars based in United States, Denmark and United Kingdom. Todd Hobbs's co-authors include Sheldon X. Kong, Wayne Weng, Jonathan Bouchard, Brian Sakurada, Alex Milinovich, Kevin M. Pantalone, Janine Bauman, Michael W. Kattan, Robert S. Zimmerman and Brian J. Wells and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and BMJ Open.

In The Last Decade

Todd Hobbs

27 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd Hobbs United States	17	484	150	120	106	105	27	783
Janine Bauman United States	14	367 0.8×	123 0.8×	100 0.8×	94 0.9×	95 0.9×	29	662
Wayne Weng United States	19	789 1.6×	226 1.5×	121 1.0×	110 1.0×	197 1.9×	34	1.2k
Michael Leutner Austria	12	307 0.6×	197 1.3×	162 1.4×	132 1.2×	118 1.1×	50	827
Juana Carretero‐Gómez Spain	15	258 0.5×	122 0.8×	124 1.0×	155 1.5×	158 1.5×	95	799
Ted Wu Australia	12	533 1.1×	156 1.0×	97 0.8×	100 0.9×	66 0.6×	31	814
Nilka Ríos-Burrows United States	5	288 0.6×	80 0.5×	101 0.8×	129 1.2×	126 1.2×	5	729
Jean-Marie Ékoé Canada	12	533 1.1×	126 0.8×	126 1.1×	127 1.2×	103 1.0×	22	868
James J. Chamberlain United States	11	460 1.0×	200 1.3×	121 1.0×	102 1.0×	141 1.3×	17	913
A. D. Morris United Kingdom	13	634 1.3×	143 1.0×	141 1.2×	67 0.6×	123 1.2×	19	990
Marco Comaschi Italy	15	825 1.7×	136 0.9×	363 3.0×	72 0.7×	102 1.0×	34	1.2k

Countries citing papers authored by Todd Hobbs

Since Specialization

Citations

This map shows the geographic impact of Todd Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Hobbs more than expected).

Fields of papers citing papers by Todd Hobbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Hobbs. The network helps show where Todd Hobbs may publish in the future.

Co-authorship network of co-authors of Todd Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Hobbs. A scholar is included among the top collaborators of Todd Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Hobbs. Todd Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison, Stephen A., Patrick Mayo, Todd Hobbs, et al.. (2025). Rencofilstat Treatment Improves Liver Function in MASH With Advanced Fibrosis as Quantified by HepQuant DuO. Liver International. 45(3). e70036–e70036. 1 indexed citations

Visaria, Jay, et al.. (2020). Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study. SHILAP Revista de lepidopterología. 1 indexed citations

Pantalone, Kevin M., Anita D. Misra‐Hebert, Todd Hobbs, et al.. (2020). The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care. 43(8). 1910–1919. 34 indexed citations

Weng, Wayne, Sheldon X. Kong, Rahul Ganguly, et al.. (2020). The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes. Endocrinology Diabetes & Metabolism. 3(2). e00106–e00106. 8 indexed citations

Visaria, Jay, Neeraj N. Iyer, Amit D. Raval, et al.. (2020). <p>Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study</p>. ClinicoEconomics and Outcomes Research. Volume 12. 423–434. 20 indexed citations

Weng, Wayne, Ye Tian, Sheldon X. Kong, et al.. (2020). Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting. SHILAP Revista de lepidopterología. 6(1). 5–5. 20 indexed citations

Gabbay, Robert A., Christine Beebe, John K. Cuddeback, et al.. (2020). Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association. Clinical Diabetes. 38(4). 371–381. 56 indexed citations

Ji, Xinge, Elizabeth R. Pfoh, Alex Milinovich, et al.. (2020). Association between shared medical appointments and weight loss outcomes and anti‐obesity medication use in patients with obesity. Obesity Science & Practice. 6(3). 247–254. 17 indexed citations

Weng, Wayne, Ye Tian, Sheldon X. Kong, et al.. (2019). The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States. Endocrinology Diabetes & Metabolism. 2(3). e00076–e00076. 43 indexed citations

10.

Visaria, Jay, Neeraj N. Iyer, Amit D. Raval, et al.. (2019). Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage Population. Clinical Therapeutics. 41(8). 1522–1536.e1. 14 indexed citations

11.

Weng, Wayne, et al.. (2019). Longitudinal analysis of atherosclerotic cardiovascular disease risk and healthcare costs in newly diagnosed type 2 diabetes in a real-world setting. Journal of Diabetes and its Complications. 34(5). 107500–107500. 3 indexed citations

12.

Willey, Vincent J., Sheldon X. Kong, Bingcao Wu, et al.. (2018). Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies.. PubMed. 11(6). 310–318. 17 indexed citations

13.

Ganguly, Rahul, Ye Tian, Sheldon X. Kong, et al.. (2018). Persistence of newer anti-obesity medications in a real-world setting. Diabetes Research and Clinical Practice. 143. 348–356. 49 indexed citations

14.

Pantalone, Kevin M., Anita D. Misra‐Hebert, Todd Hobbs, et al.. (2018). Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease. Cardiovascular Diabetology. 17(1). 54–54. 38 indexed citations

15.

Weng, Wayne, et al.. (2018). Trends in comorbidity burden and treatment patterns in type 2 diabetes: Longitudinal data from a US cohort from 2006 to 2014. Diabetes Research and Clinical Practice. 142. 345–352. 6 indexed citations

16.

Pantalone, Kevin M., Todd Hobbs, Kevin Chagin, et al.. (2017). Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open. 7(11). e017583–e017583. 156 indexed citations

17.

Weng, Wayne, Edward S. Kimball, Todd Hobbs, et al.. (2016). Decreasing incidence of type 2 diabetes mellitus in the United States, 2007–2012: Epidemiologic findings from a large US claims database. Diabetes Research and Clinical Practice. 117. 111–118. 27 indexed citations

18.

Weng, Wayne, Edward S. Kimball, Todd Hobbs, et al.. (2016). Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012. Clinical Therapeutics. 38(6). 1314–1326. 8 indexed citations

19.

King, Allen B., Akio Kuroda, Munehide Matsuhisa, & Todd Hobbs. (2016). A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes. Current Diabetes Reports. 16(9). 83–83. 26 indexed citations

20.

Pantalone, Kevin M., Todd Hobbs, Brian J. Wells, et al.. (2015). Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system. BMJ Open Diabetes Research & Care. 3(1). e000093–e000093. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact